Leerink: Medivation Buyout 'Inevitable,' AstraZeneca And AbbVie Most Likely Buyers
April 25, 2016 at 10:51 AM EDT
Leerink’s Geoffrey C. Porges believes that acquirer interest in Medivation Inc (NASDAQ: MDVN) and the appreciation in the stock ...